NR4A1 and breast cancer: BC is highly heterogeneous and mainly classified according to molecular features (hormone receptors, HER2, and Ki67) into luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)- enriched, and basal-like, which is a subtype of triple negative BC (TNBC) [16].